Business Details
30 Years
experience
Emergency
services
Specialty Pharmaceutical Development & Distribution Solutions
Methapharm is a specialty pharmaceutical company dedicated to developing, acquiring, licensing, and promoting healthcare products across North America. Established in 1996 as a spin-off from an active pharmaceutical ingredients (API) group, we collaborate with healthcare practitioners, researchers, and global pharmaceutical companies to deliver innovative solutions that address unmet medical needs. Our focus areas include respiratory, allergy, central nervous system (CNS), neonatology, and hospital products, with a mission to enhance patient care through accessible specialty therapies. We operate licensed distribution facilities in all 50 U.S. states and Canada, supporting our comprehensive capabilities in drug development and commercialization. With decades of collective leadership experience, our team drives partnerships and product development to improve quality of life.Our strategic expansion into international markets aims to broaden access to diagnostic products. Backed by rigorous regulatory expertise and a commitment to quality, we ensure consistent supply chains and compliance with global standards. Our cross-functional teams specialize in scientific affairs, quality assurance, medical affairs, and business development to deliver reliable healthcare solutions. By fostering long-term relationships with industry partners, we maintain a dynamic product pipeline aligned with evolving clinical demands. Our corporate values emphasize transparency, innovation, and ethical practices in all aspects of pharmaceutical development and distribution.
Services
Respiratory Products
Allergy Therapeutics
CNS Pharmaceuticals
Neonatology Drugs
Hospital Pharmaceuticals
Details
- Year established: 1996
Highlights and features
- We have over 30 years of experience in pharmaceutical development and distribution
- Licensed in all 50 U.S. states and Canada for comprehensive market access
- Partner with leading global pharmaceutical companies for innovative product pipelines
- Focused on addressing unmet medical needs with specialty therapeutic solutions
- Maintain rigorous quality assurance standards across all distribution channels
Services
Respiratory Products
Our respiratory product line addresses chronic and acute pulmonary conditions through innovative inhalation therapies. Leveraging decades of formulation expertise, we develop targeted treatments for asthma, COPD, and emerging respiratory diseases. These FDA-approved medications combine advanced delivery systems with rigorous quality controls to ensure patient safety and efficacy.
Allergy Therapeutics
Specializing in allergy management, our therapeutic portfolio includes immunotherapies and emergency response medications. Through strategic partnerships with biotech innovators, we commercialize cutting-edge solutions for seasonal allergies, food allergies, and anaphylaxis. Our products meet stringent regulatory standards while prioritizing patient accessibility and affordability.
CNS Pharmaceuticals
Our central nervous system (CNS) pharmaceuticals target neurological disorders including epilepsy, migraines, and neurodegenerative diseases. Partnering with research institutions, we advance novel treatments from clinical development to market distribution. Our quality assurance protocols ensure consistent formulation and compliance with international pharmacopeia standards.
Neonatology Drugs
Critical care medications for neonatal intensive care units form a core component of our specialty offerings. These precisely dosed formulations address unique developmental needs of premature and newborn infants. Our neonatology products undergo specialized stability testing and adhere to strict pediatric formulation guidelines set by regulatory authorities.
Hospital Pharmaceuticals
Comprehensive pharmaceutical solutions for hospital settings include injectables, IV solutions, and critical care medications. Our hospital-grade products meet exacting sterility and packaging requirements for use in operating rooms, emergency departments, and inpatient facilities. We provide bulk distribution systems and just-in-time inventory management for healthcare institutions.
People
Craig Baxter
CEO / President
With over 30 years in pharmaceutical leadership, Craig acquired Methapharm interest in 2015 after executive roles at Apotex and Sherfam. His expertise spans global sales, manufacturing, and hospital charity governance.
Chris Calenti
Executive Vice President / CLO
A licensed attorney with dual pharmacy and legal expertise, Chris leads business development since joining Methapharm. His multidisciplinary approach combines 20 years of commercial experience in pharmaceutical licensing and regulatory frameworks.
Sharron Brownlee
Vice President - North America, Specialty
Sharron oversees North American specialty sales with 20 years in pharmaceutical market access. Her Harvard-certified expertise in business analytics drives strategic partnerships and market expansion initiatives across healthcare sectors.
Matthew Baxter
Vice President, Respiratory
As respiratory division head, Matthew brings a decade of product development experience. His chemical engineering background from the University of Toronto supports technical oversight of diagnostic imaging agents and respiratory formulations.
John Zanin
Director of Operations
John manages global supply chains with 20+ years of pharmaceutical manufacturing expertise. From APIs to finished dosage forms, his operations leadership ensures quality control across Methapharm's 100+ product portfolio.
Questions
What therapeutic areas does Methapharm specialize in?
We specialize in respiratory, allergy, central nervous system (CNS), neonatology, and hospital pharmaceuticals, with a focus on unmet medical needs and specialty therapies.
Are Methapharm products available internationally?
While our core operations focus on North America, we're expanding our international network for diagnostic products through strategic partnerships in Europe and emerging markets.
What quality assurance measures does Methapharm implement?
Our quality assurance spans GMP compliance, stability testing, and regulatory oversight across 15+ years of QA leadership, covering APIs, biologicals, and finished pharmaceutical forms.
Does Methapharm offer emergency pharmaceutical supply options?
Yes, we provide 24/7 emergency SAP drug access in Canada through CPDN at 1-877-859-6336 for urgent medical requirements outside regular distribution channels.
